Efficacy analysis of tyrosine kinase inhibitors on rare non-small cell lung cancer patients harboring complex EGFR mutations. [electronic resource]
Producer: 20151103Description: 6104 p. digitalISSN:- 2045-2322
- Adenocarcinoma, Bronchiolo-Alveolar -- drug therapy
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride
- Female
- Gefitinib
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Protein Kinase Inhibitors -- therapeutic use
- Quinazolines -- therapeutic use
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.